Expert Opinion on Pharmacotherapy
ISSN 1465-6566 · Taylor & Francis · United Kingdom · active 1958–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Expert Opinion on Pharmacotherapy a predatory journal?
Our screening does not flag Expert Opinion on Pharmacotherapy. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Expert Opinion on Pharmacotherapy indexed in Scopus or Web of Science?
Per our venue index, Expert Opinion on Pharmacotherapy appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Expert Opinion on Pharmacotherapy's impact?
Papers in Expert Opinion on Pharmacotherapy are cited about 3.2 times each within two years of publication, and Scimago places it in Q2, with an h-index of 116. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Expert Opinion on Pharmacotherapy open access?
We hold no reliable open-access classification for Expert Opinion on Pharmacotherapy. Check the journal's own site for its access model and any article processing charge.